EX-10.18 1
from 10-K
7 pages
We Are Pleased to Offer You an International Assignment From the Netherlands to the United States With Catalent Pharma Solutions LLC. We Trust This Will Be a Mutually Beneficial Experience for You as Well as for the Company. This Letter Confirms the Terms and Conditions That Apply to Your Assignment as President, Division Head Biomodalities Based in Somerset, New Jersey. I.ASSIGNMENT Summary •home Country: The Netherlands •host Country: The United States •employer: Catalent Pharma Solutions, LLC •position Title: President, Division Head Biomodalities •manager While on Assignment: Biologics Committee (Through Its Representative, Alessandro Maselli, President & CEO) •citizenship/Permanent Resident Status: The Netherlands •annual Base Salary: US$500,000 Paid From the Netherlands as €494,218 •management Incentive Plan Target: US$400,000 Paid From the Netherlands in Local Currency •long Term Incentive Plan Target: US$650,000 •scheduled Assignment Start Date: October 17th, 2022 •scheduled Assignment End Date: November 30, 2025 •assignment Duration: Thirty-Six (36) Months •assignment Policy: International Long-Term Assignment
12/34/56